GSK and Save the Children: An Ambitious Partnership
GSK PULSE volunteer Ivy tells why she is excited about this partnership
By Michael M, GSK Communications
Today, we announced an ambitious new partnership with Save the Children to save the lives of a million of the poorest children in the world.
While good progress has been made in recent years, almost seven million children die each year through lack of access to basic healthcare, vaccines or nutritious food. Through these and other initiatives, the partnership aims to help save the lives of one million children in the next five years. We're working together in a very different way--sharing expertise, resources, reach and influence to tackle some of the leading causes of childhood deaths.
GSK and Save the Children have been working together for eight years on a number of public health projects, including our initiative to reinvest 20% of the profits we make in the least-developed-countries in community programs to strengthen healthcare infrastructure, primarily through the training of community health workers. We've even sent a number of employees to work with them for extended assignments through our employee volunteer program called PULSE.
Ivy, who works in our Philadelphia office, recently returned from a PULSE assignment with Save the Children. Watch her describe why she is so excited about this new collaboration.
GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com
Save the Children - Save the Children works in more than 120 countries and helps to save children's lives, fight for their rights and help them fulfil their potential. For more information visit: www.savethechildren.org.uk
